BR100 Decreased By (-0%)
BR30 Decreased By (-0.4%)
KSE100 Increased By (0.14%)
KSE30 Increased By (0.05%)
AGHA 6.62 Increased By ▲ 0.01 (0.15%)
BECO 4.32 Increased By ▲ 0.08 (1.89%)
BML 60.30 Decreased By ▼ -1.15 (-1.87%)
BOP 28.80 Decreased By ▼ -0.01 (-0.03%)
CNERGY 12.87 Increased By ▲ 0.07 (0.55%)
CSIL 5.43 Decreased By ▼ -0.13 (-2.34%)
FCCL 51.79 Decreased By ▼ -0.20 (-0.38%)
FFL 14.09 Increased By ▲ 0.07 (0.5%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 6.08 Increased By ▲ 0.17 (2.88%)
KOSM 5.39 Decreased By ▼ -0.05 (-0.92%)
LOTCHEM 25.49 Decreased By ▼ -0.33 (-1.28%)
MLCF 90.08 Decreased By ▼ -0.37 (-0.41%)
NBP 158.30 Decreased By ▼ -0.97 (-0.61%)
NCPL 48.90 Decreased By ▼ -0.18 (-0.37%)
NPL 53.20 Increased By ▲ 0.77 (1.47%)
OGDC 298.90 Decreased By ▼ -3.35 (-1.11%)
PACE 9.77 Decreased By ▼ -0.09 (-0.91%)
PAEL 33.80 Increased By ▲ 0.07 (0.21%)
PIBTL 13.75 Increased By ▲ 0.04 (0.29%)
PPL 218.70 Decreased By ▼ -0.55 (-0.25%)
PRL 106.97 Increased By ▲ 3.21 (3.09%)
PTC 53.81 Decreased By ▼ -1.25 (-2.27%)
SSGC 22.92 Decreased By ▼ -0.10 (-0.43%)
TBL 9.53 Decreased By ▼ -0.24 (-2.46%)
TELE 7.10 Decreased By ▼ -0.13 (-1.8%)
TPL 20.46 Decreased By ▼ -0.21 (-1.02%)
TPLP 11.82 Decreased By ▼ -0.05 (-0.42%)
TREET 23.47 Decreased By ▼ -0.13 (-0.55%)
TRG 56.46 Increased By ▲ 0.99 (1.78%)
By

LONDON: The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.

The data supports the safety of this model which could theoretically provide a "plug and play" platform for testing therapies and vaccines using the original COVID-19 strain as well as variants of the virus, Open Orphan, which carried out the study, said in a statement.

Omicron sub-variant found in 57 countries: WHO

Open Orphan is running the project, launched a year ago, with Imperial College London, the UK government's vaccines task force and the clinical company hVIVO.

Comments

Comments are closed for this article.